Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
      • The Challenge Initiative Platform
      • Call for Abstracts
      • The Responsive Feedback Approach
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Alerts
  • Visit GHSP on Facebook
  • Follow GHSP on Twitter
  • RSS
  • Find GHSP on LinkedIn
COMMENTARY
Open Access

Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally

Brian J. Morris, Stephen Moreton, John N. Krieger and Jeffrey D. Klausner
Global Health: Science and Practice August 2022, 10(4):e2100811; https://doi.org/10.9745/GHSP-D-21-00811
Brian J. Morris
aSchool of Medical Sciences, University of Sydney, Sydney, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: brian.morris@sydney.edu.au
Stephen Moreton
bCircFacts, Warrington, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John N. Krieger
cDepartment of Urology, University of Washington School of Medicine, Seattle, WA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey D. Klausner
dDepartment of Medicine, Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • Comments
  • PDF
Loading

Key Messages

  • Population-based studies in high-income countries have generally failed to find protection of male circumcision (MC) against sexually transmitted infections (STIs). This stems from the overrepresentation of men who have sex with men (MSM) in national STI statistics, with inability of MC to protect against STIs during receptive anal intercourse.

  • Studies of men from settings where MC is performed early in life showed lower prevalence of STIs in circumcised men.

  • However, a Danish database study reported an association of early MC with an increased risk of STIs. The study’s findings were underpowered, contained questionable statistical methods, failed to consider receptive anal intercourse by MSM, and failed to adequately exclude non-ethnic Danes.

  • Biological plausibility of infant MC in reducing infection risk is supported by its well-established ability to protect against infant urinary tract infections, as well as pathogenic bacteria and other microorganisms, across all ages. Childhood MC appears effective for protection against various specific STIs irrespective of the country where it was performed.

MALE CIRCUMCISION FOR HIV AND STI PREVENTION IN MEN

We review the evidence concerning whether or not male circumcision (MC) performed early in life reduces the risk of HIV and other sexually transmitted infections (STIs). We first present findings for men, and then for children. In so doing, we critically evaluate 2 recent studies in which data appeared to contradict the premise of MC being protective. Our commentary has important policy implications for the performance of infant MC globally.

High-quality research on male circumcision (MC) shows varying degrees of protection against a number of heterosexually acquired sexually transmitted infections (STIs)1,2 including HIV,3,4 oncogenic human papillomavirus (HPV) types,5–12 herpes simplex virus type 2,13–16 genital ulcer disease,17,18 syphilis,19–21 Trichomonas vaginalis,22 Mycoplasma genitalium,23 and chancroid.19 However, MC does not protect against low-risk HPV genotypes that cause anogenital warts because these infect the anogenital region more broadly (i.e., MC is less effective).24 Nor does MC protect against urogenital urethritis caused by Chlamydia trachomatis or Neisseria gonorrhoeae.25–27 We use the term STIs to in most cases refer to those that MC protects against (Table 1).28–34

View this table:
  • View inline
  • View popup
TABLE 1

STIs That Male Circumcision Protects Against

Much of the high-quality data on MC for STI prevention originated from large HIV RCTs involving mostly heterosexual men* in South Africa, Kenya, and Uganda.35–37 In South Africa, Kenya, and Uganda, most STIs involve heterosexual exposure. The strong protective effect of MC against HIV infection led the World Health Organization and the Joint United Nations Programme on HIV/AIDS,38 supported by funding from the U.S. President’s Emergency Plan for AIDS Relief, United States Agency for International Development, and the Bill and Melinda Gates Foundation, to roll out voluntary medical MC programs across 15 priority sub-Saharan African countries, which, accompanied by other measures, has reduced HIV incidence substantially.39 Major medical bodies and some MC opponents now accept that MC reduces HIV infection and perhaps other STIs in men in sub-Saharan Africa. However, some continue to question whether MC in infancy and childhood offers similar protection and whether the findings in sub-Saharan Africa apply to countries with higher socioeconomic status.

Evidence-based reviews by the American Academy of Pediatrics40,41 and the U.S. Centers for Disease Control and Prevention42,43 led to recommendations favoring MC in infancy and childhood to reduce the risk of HIV, other STIs, and an array of additional medical conditions in the United States.

The most recent meta-analysis found MC provides 72% protection against heterosexually acquired HIV infection.3 Because most of the current data are based on findings in sub-Saharan Africa, some have argued that these may not apply to high-income countries (HICs). To support this premise, it has been pointed out that MC is not associated with overall HIV prevalence in those HIC settings. This was apparent in recent Canadian studies.44,45

Because most of the current data on protection of MC against STIs are based on findings in sub-Saharan Africa, some have argued that these data may not apply to high-income countries.

A key difference between data from sub-Saharan Africa and HICs stems from the extent of particular sexual behaviors, notably, receptive anal intercourse. Men in the sub-Saharan African RCTs were mostly heterosexual, whereas data from HICs come from a mixture of heterosexual men and men who have sex with men (MSM). Crucially, it should be obvious that MC would offer no protection against STIs among MSM who adopt the receptive role during anal intercourse. As a result, studies of HIV incidence and HIV prevalence in men overall in HICs have failed to find a protective effect of MC against HIV infection.46–48 Most STIs transmitted to receptive MSM would presumably be anorectal. Although the collection of anorectal swabs for testing and diagnosing STIs was not performed in all studies, for HIV (and certain other STIs), diagnosis is done instead by seropositivity. The most recent meta-analysis48 identified studies in Sydney, Australia,49 and Buenos Aires, Argentina,50 with HIV data for both receptive and insertive MSM. Each study found that MC protected against HIV infection in MSM who practiced insertive anal intercourse. The study in Sydney involved 1,426 initially HIV-negative MSM, one-third of whom preferred the insertive role during unprotected anal intercourse.49 Of these insertive MSM, HIV seroconversions were seen in 2 of 279 circumcised MSM and 5 of 156 uncircumcised MSM (adjusted hazard ratio=0.11; 95% confidence interval [CI]=0.01, 0.92). In the Buenos Aires study of 500 MSM, HIV positivity was detected in 0 of 33 circumcised and 34 of 231 (14.8%) uncircumcised MSM (P=.02).

Failure to show a protective effect of MC against HIV in HICs may stem from not taking into consideration differences in risk for contrasting sexual practices among MSM. We illustrate this by an examination51 of the study findings by Nayan et al.44 Among 569,950 Canadian men from Ontario, HIV prevalence was only 2% (nonsignificantly) lower in the 203,588 (35.7% of the sample) who were circumcised (83% circumcised in infancy) compared with the 366,362 who were uncircumcised. Another recent Canadian study found that 14% of HIV cases in men occurred in heterosexuals, while 86% occurred in MSM.45 Since there were no data on the role taken during anal intercourse in these studies, we used data from the high-quality longitudinal study in Sydney,49 which, in contrast to Buenos Aires, is a setting more comparable to Ontario. The Sydney study found that during anal intercourse, 69% of MSM adopt the receptive role, for which MC offers no protection. It found that 33.1% of MSM practiced the insertive role; among these participants, 75.7% of HIV infections could be attributed to being uncircumcised. In contrast, among all participants, 8.7% of HIV infections could be attributed to being uncircumcised.

Failure to show a protective effect of MC against HIV in HICs may stem from not taking into consideration differences in risk for contrasting sexual practices among MSM.

A Cochrane meta-analysis has shown that circumcised insertive MSM are at 73% lower HIV risk.47 Using the Sydney data for percentage of MSM who are receptive49 and data for percentage of men who are MSM in Canada,45 26.7% of HIV infections occur among insertive MSM. Adding 26.7% to the 14% of HIV infections found in heterosexual males in Canada,45 gives 40.7%, which when multiplied by 0.357 and then 0.73 gives 10.6%. And 10.6% of 203,588 gives 21,580, showing that only 3.8% of Canadian men are at lower HIV infection risk because they are circumcised. Factoring in the above, 15 of the 141 HIV cases in Nayan et al.44 were predicted to have occurred in insertive circumcised men and 126 cases in uncircumcised insertive men. A χ2 test comparing these numbers with the expected numbers (50 and 91, respectively) if circumcision had no effect, showed that circumcision reduced risk by ∼70% (χ2=38; P=7.2 x 10– 10) (Figure).51 The critics’ calculations and conclusions51 were endorsed by Nayan et al.,52 the authors of the Ontario study that was evaluated.44

FIGURE
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE

Flow Chart Showing How MC Was Strongly Associated With Reduced Risk of HIV Infection51,a

Abbreviations: MC, male circumcision; MSM, men who have sex with men.

aInclusion criteria: English language, published after 1980, unique data on HIV in relation to circumcision status were examined. Despite null results for HIV and MC in a Canadian study,44 after allowing for sexual preference45 and percentage of MSM who are insertive and receptive during anal intercourse.

Among other STIs studied by the Sydney investigators, HPV prevalence was also found to be significantly lower in circumcised MSM who adopt the insertive role during anal intercourse.53 Intriguingly, high-risk HPV has been found in 9% of foreskin samples of prepubertal boys.54

Among women, a study of serodiscordant couples found those with a circumcised male partner exhibited a nonsignificantly 38% lower risk of HIV infection.55 Systematic reviews have documented consistent evidence for protection against HPV, cervical dysplasia, cervical cancer, HSV-2, Trichomonas vaginalis, syphilis, bacterial vaginosis, and chlamydia.56,57

Studies That Included Males Circumcised in Childhood

All current RCT data on STIs and MC involve adult males in sub-Saharan Africa. It would be impractical and unethical to conduct an RCT on early childhood MC and acquisition of STIs later in life. Therefore, we searched for studies of STIs comparing men likely to have been circumcised early in life with uncircumcised men.12,53,58–79 Circumcised men in studies from HICs included mostly men who were circumcised as neonates but also some circumcised later in infancy or childhood (Table 2). In all of these men, STI risk was lower in circumcised compared with uncircumcised men. A contrary Danish study80 was not included in Table 2 and will be discussed in detail in the section analyzing contrary evidence. Table 2 also includes studies in low- and middle-income countries, all of which were on HIV. These found lower HIV prevalence among men circumcised in infancy and childhood.

View this table:
  • View inline
  • View popup
TABLE 2.

All Studies of STIs in Males Who Had Been Circumcised in Infancy or Childhooda,b

In studies of men circumcised early in life, STI risk was lower in circumcised compared with uncircumcised men.

Biological Plausibility

Biological plausibility is 1 of the 9 key criteria Bradford Hill describes as being required for causal inferences from observational studies.81 The strongest biological data suggest that the foreskin is highly susceptible to HIV infection.82–87 Inflammatory conditions and ulcerative STIs increase risk,88–92 as do coital injuries, to which uncircumcised men are prone.93–95 Risk is higher when foreskin surface area is large.96 Some protection against low levels of HIV is afforded by langerin, which is produced by the inner foreskin mucosal epithelium.97 However, langerin becomes overwhelmed at high HIV loads.97,98 Distinct lymphoid aggregates just beneath the basal membrane, which was densely populated with CD3+CD4+ T cells, and abundant superficial HIV target cells close to superficial blood and lymph vessels, provide possible anatomical explanations for the protective effect of MC against HIV infection.84,99 Breaches in the epithelial layer through trauma or inflammation, dendrites extending to the foreskin surface,83,100 and passive diffusion of HIV particles through normal foreskin epithelium, as well as through the more vulnerable underlying glans of uncircumcised men,101 may contribute to the susceptibility of an uncircumcised penis to infection.

But is foreskin retention in infancy a risk of infection by microorganisms? A common site of infection in infancy is the urinary tract. Strong data show that MC early in infancy protects against urinary tract infection. This type of infection in males is most common in infancy, affecting 1%–2% of uncircumcised boys compared to 0.1%–0.2% of boys who are circumcised.102,103 Protection, albeit progressively lower, extends over the lifespan.102 Swabs taken under the foreskin of boys aged 7 days to 11 years identified 50 bacterial isolates, most of which were multidrug-resistant strains.104 Colonization by pathogenic bacteria is much more prevalent under the foreskin of uncircumcised boys compared with the exposed glans region of circumcised boys.105–116 The foreskin is more prone to inflammation exacerbated by the predominantly anaerobic microbiome of the preputial space.109,117 Taken together, it seems biologically plausible for circumcision performed in infancy to also protect against infection of a healthy penis from HIV and other STIs later in life.

Some disregard the biology in arguing that data from African studies do not apply to HICs where sexual behaviors, such as the number of partners and condom use, may differ. Since the evidence we discuss indicates that the protective effect of MC is biological, this protection will still be present regardless of the number of partners or use of condoms.

ANALYZING CONTRARY EVIDENCE TO THE PROTECTION OF MC AGAINST STIS

Given the strong data previously mentioned supporting the ability of MC to reduce the risk of STIs, the findings of a 2022 study by Frisch and Simonsen that reported a 53% higher STI risk among males circumcised at age 0–10 years (mean 5.9 months)80 appeared anomalous. Their study involved 810,719 males born in Denmark between 1977 and 2003 and followed up between January 1977 and November 2013 (27 years in total; on average 22 years). The oldest males would thus have been 27 years of age, and mean age of all males was 22 years. STI acquisition would have occurred mostly in the period of follow-up when the subjects were old enough to be sexually active. Parent-approved nontherapeutic MC is uncommon in Denmark. After excluding MC for foreskin-related medical problems and most Muslims, only 3,375 (0.42%) of the cohort were circumcised. Of 8 STIs evaluated, significant differences were found only for anogenital warts and syphilis. There were 74 cases of warts but only 4 cases of syphilis, as we will discuss.

We critically evaluated the findings of a 2022 Danish study that reported a 53% higher STI risk among males circumcised at age 0–10 years.

We conducted a thorough critical evaluation of this study’s design, cohort used, data analyses, and interpretation, as well as their failure to consider other factors, such as sexual preference. Our findings have substantial implications for global public health.

Limitations in Cohort Used

Low Prevalence of HIV

Frisch and Simonsen found no HIV cases among 3,375 circumcised males in their study, compared with 321 among 807,344 uncircumcised males. They concluded that MC did not seem to reduce the risk of HIV infection, a conclusion that seemed to be based on a simulation study they performed in which they assumed similar rates of infection among circumcised and uncircumcised males in their study. Their conclusion is not consistent with their simulation. The simulation tested the null hypothesis of equal or higher rates of HIV acquisition in circumcised males against the alternative hypothesis that the rate is lower among circumcised males. In their results, they implied that rates of HIV infection among circumcised and intact males were not statistically significantly different.80

One might conclude that early MC could protect against HIV but that the limited number of cases was not sufficient to meet the conventional threshold of statistical significance. This conclusion is subject to the same caveat of low statistical power that applies to almost all STI analyses in their study.

Sexual Preference Not Considered

The database Frisch and Simonsen used did not record sexual preference. In Denmark, 3% of men may be homosexual and 4% bisexual.118 MSM are overrepresented in population STI statistics.45 Contrary to expectations, rather than the proportion decreasing in recent years owing to preexposure prophylaxis (PrEP), a meta-analysis has found that PrEP has been accompanied by increases in STI diagnoses, condomless sex, receptive anal intercourse, and sex with an HIV-positive partner.119 Thus, sexual orientation and role adopted during sexual activity represent potential confounding factors (see the calculations for the Canadian study44). Since most MSM receiving PrEP undergo regular anal STI screening as part of PrEP programs, such screening may help identify prevalent STIs, especially as most STIs are asymptomatic, so screening may substantially increase ascertainment. We presume that, as elsewhere, such screening includes testing rather than just self-reporting of symptoms.

Sexual orientation and role adopted during sexual activity represent potential confounding factors for risk of STIs.

Low Prevalence of MC

MC prevalence in Frisch and Simonsen’s study was only 0.42%. The extraordinarily low number of circumcised males in the study combined with a lack of consideration of sexual preferences among MSM may explain in part their failure to show a reduced risk of HIV and other STIs by childhood MC. Moreover, it would be naïve to assume that an equal proportion of circumcised and uncircumcised MSM practice receptive anal intercourse.

Low Prevalence of STIs

In Frisch and Simonsen’s study, the number of STI cases in circumcised males (besides anogenital warts, 74 cases), was very low: 2 of genital herpes, 4 of syphilis, 5 of gonorrhea, and 3 cases in total of chlamydia, granuloma inguinale, and trichomoniasis (presumably 1 case of each). The low number of events in the circumcision group meant that there was a high chance of Type II error (i.e., failure to reject the null hypothesis because statistical power is insufficient). Their regression analyses may thus suffer from overfitting and instability.

In a 2011 database study (of sexual function), Frisch et al. acknowledged instability in their statistical analyses because only 5% of the cohort used in that study was circumcised.120 Since the percentage of circumcised males in the 2022 study was very low (0.42%), instability as a factor in their analyses would weaken the reliability of the findings despite the possibility of their study being, as they claim, “by far the most powerful prospective study to date.”

The subjects were drawn from the Civil Registration System of Denmark using National Patient Register surgery codes 55620 for 1977–1995 or KKGV20 from 1996 onward. From 2004 Denmark started removing nontherapeutic MC from publicly subsidized records, thus resulting in incomplete records for circumcisions performed thereafter. But from the start of 2017 all circumcisions, at home or in a clinic, had to be registered.121 Codes for nontherapeutic circumcisions were used to exclude circumcisions for medical reasons, so contributing to the low proportion of circumcised males in their cohort. The effect of these various changes in procedures for recording circumcisions is not clear, nor was it addressed by Frisch and Simonsen.

Limitations in Interpretation

A key flaw in the Frisch and Simonsen findings is the probability that some STI events (including the largest category, anogenital warts) were actually related to the sexual partners’ MC status rather than the subjects’ own status. Because the proportion of circumcised males in their cohort was only 0.42%, the likelihood of having a circumcised sexual partner was very low and was approximately equal for the 2 groups. For MSM, the likelihood of having an uncircumcised sexual partner was approximately 99.6%.

Limitations of Hazard Ratios

Their use of the Cox proportional hazard model and their reporting of hazard ratios presents potential problems.122 Instead, Kaplan-Meier Survival Curves should have been used to describe and explore the relationship between the putative predictive factor (circumcision status) and the time to event (STI).122,123 Because a survival curve was not included, the reader cannot assess the validity of the assumption of proportional hazards. Frisch and Simonsen did not address this key assumption before selecting the Cox proportional hazards model. A Kaplan-Meier curve would assist the reader to judge whether the Cox model was appropriate.

  • Their Cox regression model used a baseline timepoint of date of birth for subjects. This seems problematic because subjects are not susceptible to the event occurring until many years after birth when they become sexually active. Boys born late in the study period would not have been sexually active. It also means that their use of “person-years” of follow-up is quite misleading because the cohort is not at risk of the event for much of the follow-up period.

  • The Cox model assumes that the event can occur only once to each subject. However, STI events often occur more than once, so a recurrent event model may be more appropriate.124 This could take the form of a generalized linear model with a Poisson or logistic link for the events as a dependent variable.

No data were provided for oncogenic HPV genotypes. These are present in 22%–45% of men in Denmark,125,126 where, as in other countries, lower prevalence has been reported in those men who are circumcised.127,128 Their study only reported data for anogenital warts, which are caused by low-risk HPV genotypes known to infect the entire anogenital region, rather than the distal penis where high-risk HPV infects and which has a prevalence in Denmark of up to 11%.127

Given the calculations above for HIV and sexual preference, the majority of the 74 cases of anogenital warts found in circumcised males could be in receptive MSM. Taken together, MC status should have no overall impact on risk of most anogenital warts.

Failure to Exclude Ethnic and Cultural Minority Groups in Which MC Is Common

Frisch and Simonsen acknowledged that non-ethnic Danes, specifically Muslims, may have different sexual behaviors, so they sought to exclude them. Therefore, they excluded males whose parent or grandparent was born in 17 countries with a Muslim majority (Turkey, Iraq, Pakistan, Iran, Somalia, Lebanon, Afghanistan, Morocco, Egypt, Syria, Indonesia, Algeria, Jordan, Bangladesh, Kuwait, Tunisia, and Kosovo). While doing so may have helped reduce 1 element of confounding, it also reduced power. As a result, of the 810,719 supposed Danish-born non-Muslim males in their study, only 3,375 (0.42%) had undergone MC at ages 0–10 years. The fact that Denmark is a non-circumcising culture raises the question, what was the ethnicity of the 3,375 circumcised males? This is a key issue in considering unknown and unaccounted for confounding factors that might exist in their data.

Socioeconomic factors, discrimination, and distrust influence access to health care and the likelihood of contracting an STI. These affect minority groups disproportionately. As the U.S. Centers for Disease Control and Prevention explains on its website129:

There are higher rates of STDs among some racial or ethnic minority groups compared to whites … these higher rates are not caused by ethnicity or heritage, but by social conditions that are more likely to affect minority groups. Factors such as poverty, large gaps between the rich and the poor, fewer jobs, and low education levels can make it more difficult for people to stay sexually healthy … In communities with higher STD rates, sexually active people may be more likely to get an STD because they have greater odds of selecting a partner who is infected.

This is seen as well in European and British settings where ethnic minorities are often at greater risk for STIs.130–132

While it may be argued that second- or third-generation immigrants, as those included in Frisch and Simonsen’s cohort, may be assimilated into Danish ways, the extent of this is unquantifiable. They are also more likely to associate (and have sex) with new immigrants of the same ethnicity or visit their ancestral homelands where STIs may be more prevalent (as in the United States and sub-Saharan Africa) and contract an STI there, putting them at greater risk than their ethnic Danish peers. While Danish people may also travel abroad, the destination chosen would not be influenced by the factor of ethnic origin that is more likely to apply to ethnic minorities. Again, these effects cannot be quantified.

With ethnicity a source of confounding, in studies of sexual health the cohort should be ethnically homogenous unless ethnicity is being studied. The European Centre for Disease Prevention and Control recognizes the importance of collecting data on ethnicity in relation to HIV in Europe, observing that ethnic minorities in Europe are disproportionately affected by HIV.133

In studies of sexual health, the cohort should be ethnically homogenous unless ethnicity is being studied.

Frisch and Simonsen stated that after excluding subjects from the 17 Muslim countries, no other single country accounts for more than 0.1% of immigrants to Denmark. Thus, they did not exclude Jewish, American, African, and perhaps males born to other ethnicities, cultures, or races in which circumcision is commonly practiced. Statistics for immigrants in Denmark are available from 1980 onward at www.statbank.dk, and further data on the proportion of Muslims in various countries are available from other publications.134–138 The Statistics Denmark database139 documents an enormous increase in the number of Muslims in Denmark after 1996, when an influx of Bosnians began. However, most of the children born that recently would not have been sexually active during Frisch and Simonsen’s study period ending in 2013.

Therefore, we extracted data for the year 1980 (Table 3), close to the start of the period used by Frisch and Simonsen, even though this would have resulted in an underestimate, because immigration increased throughout the study period.

View this table:
  • View inline
  • View popup
TABLE 3.

Circumcised Males From Countries and Cultures in 1980 That Were Not Excluded by Frisch and Simonsen Study

In Table 3, to be conservative, we excluded countries with fewer than 10 citizens in Denmark in 1980 as well as countries with populations in which Muslims represented fewer than 10%. Of the countries included, there was a total of 2,326 Muslim immigrants. As some European countries have very large immigrant communities in Denmark on account of proximity and, in many cases, membership of the European Economic Community or European Free Trade Association, even their modest Muslim populations would contribute a significant proportion of Muslims, assuming their movements are as great as their non-Muslim countryfolk. We also excluded countries that contribute fewer than 10 Muslims (Table 3). This resulted in the identification of a further 1,021 Muslims. Table 4 shows data for non-Muslim cultures that practice early MC and have a significant presence in Denmark. To be conservative, we included only countries in which more than 70% of males are circumcised. The number of non-Muslim immigrants from these countries was 7,592.

View this table:
  • View inline
  • View popup
TABLE 4.

Non-Muslim Immigrants in 1980 in Denmark From Countries in Which Prevalence of Male Circumcision Is More Than 70% But That Were Not Excluded by Frisch and Simonsen Study

Taken together, for 1980, the data suggests a total of 3,347 Muslim immigrants and an additional 7,592 non-Muslim immigrants from countries and cultures that perform MC in childhood but which were not excluded by Frisch and Simonsen. The population of Denmark in 1980 was 5,123,029, of whom 16,394 (0.32%) were Muslim.136 The additional 3,347 Muslims we found constitute 0.07% of the Danish population and the 7,592 non-Muslims another 0.15%.

The number of Jews in Denmark is estimated at approximately 7,000 individuals.140 Ever since around 2000, it has not been possible to have nontherapeutic circumcision of boys performed at public hospitals in Denmark, as was previously the case. Circumcisions of Jewish boys take place in private homes and are performed by a mohel (traditional Jewish circumciser) under the supervision of a licensed medical doctor in accordance with current Danish rules. In addition to this, an unknown number of circumcisions of boys with a Jewish family background are performed at private medical clinics.

After adding a further 0.2% (approximately 10,000) that were non-Israeli Jews, the total becomes 0.42%. Assuming these people give birth at a similar rate as ethnic Danes (which is likely conservative as immigrants tend to have higher birth rates overall) then their offspring will account for a substantial proportion of the 0.42% of Frisch and Simonsen’s cohort who had undergone non-therapeutic MC. Therefore, our calculations suggest that their cohort likely suffers from substantial residual confounding from ethnicity.

Failure to Address Biological Plausibility

Frisch and Simonsen did not address the question of biological plausibility (as we discussed earlier).

Other Issues

The same Danish patient database was included in previous studies by Frisch et al. of sexual function and pleasure,120 autism spectrum disorder,141 and meatal stenosis.142 The percentage of circumcised males in those studies was approximately tenfold higher than their recent study. Problems with statistical analyses, inclusion criteria, and other issues in each study were identified by the present authors143–145 and others.146–149 Additionally, those earlier studies used the same algorithm to control for ethnicity but, as we have shown in this article, that algorithm failed.

Frisch and Simonsen use the term “intact” for uncircumcised males, which implies that circumcised males are missing something important, whereas the commonly used term, “uncircumcised,” is well established in both medical and lay literature.

Examples of obfuscation are also apparent. Instead of referring to negative findings for STIs other than genital herpes as nonsignificant, they refer to them as “inconspicuous.” Another feature is selective citation of outlier studies and opinion pieces but not the rebuttals of each.150

Under ideal circumstances, the best study design to address whether early MC reduced STI risk would be a large, well-designed RCT with follow-up of at least 20 years in a setting in which there was a roughly similar proportion of circumcised and uncircumcised men to ensure adequate power. However, such a study would be impractical, costly, and, given the existing biological data showing MC protects against particular STIs in populations in which most men were circumcised in infancy, likely to be deemed unethical by ethics committees.

CONCLUSIONS

Circumcision early in life has been associated with the reduced risk of HIV and other STIs in men during heterosexual intercourse and during insertive anal intercourse in MSM. In HICs, MSM disproportionately contribute to STI prevalence. This, and lack of protection afforded by MC in men who assume the receptive role during anal intercourse, account for the failure in population studies to detect a role for MC in protecting against STIs in such settings. We illustrated this by more deeply analyzing data from the Canadian study by Nayan et al.44

The Frisch and Simonsen study that found early circumcision did not protect against HIV or other STIs80 was related to very low case numbers, very low MC prevalence of the Danish cohort studied, failure to consider the issues above of sexual practices among MSM, failure to adequately exclude males with parents from countries in which childhood MC is common, and biological implausibility.

A study in the United States should be best able to test the hypothesis that infant MC protects against STIs later in life. This is because (1) the prevalence of circumcised and uncircumcised males in the United States is similar, (2) most circumcisions in the United States occur in early infancy, (3) the U.S. population size is large, (4) STIs are prevalent in the population, and (5) the United States has a large number of national government health-related datasets.151

Acknowledgments

We thank Jim G. Matthews, MStat, Sydney Informatics Hub, University of Sydney, for expert critical advice on statistical analyses.

Funding

Brian J. Morris’ research is supported by a U.S. National Institutes of Health Center of Biomedical Research Excellence grant 1P20GM125526-01A1.

Author contributions

Brian J. Morris evaluated the data and prepared the initial draft. All authors provided critical input to successive drafts and approved the final version.

Competing interests

Brian J. Morris reports that he is Secretary of the Circumcision Academy of Australia, a government-registered incorporated medical association. Stephen Moreton is an editor of, and contributor to, CircFacts, a website that critically examines arguments opposing male circumcision. John Krieger is the co-inventor of a circumcision device patented by the University of Washington. The authors have no financial, religious, or other affiliations that might influence the topic of male circumcision.

Footnotes

  • ↵* We emailed the trials’ principal investigators (PIs) to determine how many participants were men who have sex with men (MSM). The Kenya trial PI stated that although MSM were not excluded, when participants were asked if they had ever had sex with another man, only 2 responded yes. The Uganda trial PI stated participants weren’t asked about homosexual intercourse in the trial, but our prior studies suggested that this is extremely rare and not culturally accepted in this rural African population.

Notes

Peer Reviewed

First published online: August 12, 2022.

Cite this article as: Morris BJ, Moreton S, Krieger JN, Klausner JD. Infant circumcision for sexually transmitted infection risk reduction globally. Glob Health Sci Pract. 2022;10(4):e2100811. https://doi.org/10.9745/GHSP-D-21-00811

  • Received: December 17, 2021.
  • Accepted: June 21, 2022.
  • Published: August 30, 2022.
  • © Morris et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-21-00811

REFERENCES

  1. 1.↵
    1. Gross GE,
    2. Tyring SK
    Morris BJ Castellsague X. The role of circumcision in preventing STIs. In: Gross GE, Tyring SK, eds. Sexually Transmitted Infections and Sexually Transmitted Diseases. Springer-Verlag; 2011:715–739. doi:10.1007/978-3-642-14663-3_54
    OpenUrlCrossRef
  2. 2.↵
    1. Tobian AAR,
    2. Kacker S,
    3. Quinn TC
    . Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med. 2014;65(1):293–306. doi:10.1146/annurev-med-092412-090539. pmid:24111891
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Sharma SC,
    2. Raison N,
    3. Khan S,
    4. Shabbir M,
    5. Dasgupta P,
    6. Ahmed K
    . Male circumcision for the prevention of human immunodeficiency virus (HIV) acquisition: a meta-analysis. BJU Int. 2018;121(4):515–526. doi:10.1111/bju.14102. pmid:29232046
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Sansom SL,
    2. Prabhu VS,
    3. Hutchinson AB,
    4. et al
    . Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One. 2010;5(1):e8723. doi:10.1371/journal.pone.0008723. pmid:20090910
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Castellsagué X,
    2. Bosch FX,
    3. Munoz N
    , et al. Male circumcision, penile human papillomavirus infection, and cervical cancer. N Engl J Med. 2002;346(15):1105–1112. doi:10.1056/nejmoa011688. pmid:11948269
    OpenUrlCrossRefPubMed
  6. 6.
    1. Backes DM,
    2. Bleeker MCG,
    3. Meijer CJLM,
    4. et al
    . Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. Int J Cancer. 2012;130(8):1888–1897. doi:10.1002/ijc.26196. pmid:21618520
    OpenUrlCrossRefPubMed
  7. 7.
    1. Tobian AAR,
    2. Serwadda D,
    3. Quinn TC,
    4. et al
    . Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360(13):1298–1309. doi:10.1056/NEJMoa0802556. pmid:19321868
    OpenUrlCrossRefPubMed
  8. 8.
    1. Auvert B,
    2. Sobngwi-Tambekou J,
    3. Cutler E,
    4. et al
    . Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis. 2009;199(1):14–19. doi:10.1086/595566. pmid:19086814
    OpenUrlCrossRefPubMed
  9. 9.
    1. Gray RH
    . Male circumcision for preventing HPV infection. Nat Rev Urol. 2009;6(6):298–299. doi:10.1038/nrurol.2009.96. pmid:19498404
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Gray RH,
    2. Wawer MJ,
    3. Serwadda D,
    4. Kigozi G
    . The role of male circumcision in the prevention of human papillomavirus and HIV infection. J Infect Dis. 2009;199(1):1–3. doi:10.1086/595568. pmid:19086812
    OpenUrlCrossRefPubMed
  11. 11.
    1. Albero G,
    2. Castellsagué X,
    3. Giuliano AR,
    4. Bosch FX
    . Male circumcision and genital human papillomavirus: a systematic review and meta-analysis. Sex Transm Dis. 2012;39(2):104–113. doi:10.1097/OLQ.0b013e3182387abd. pmid:22249298
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Homfray V,
    2. Tanton C,
    3. Miller RF,
    4. et al
    . Male circumcision and STI acquisition in Britain: evidence from a national probability sample survey. PLoS One. 2015;10(6):e0130396. doi:10.1371/journal.pone.0130396. pmid:26083250
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Tobian AAR,
    2. Ssempijja V,
    3. Kigozi G,
    4. et al
    . Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS. 2009;23(12):1589–1594. doi:10.1097/QAD.0b013e32832d4042. pmid:19474649
    OpenUrlCrossRefPubMed
  14. 14.
    1. Tobian AAR,
    2. Charvat B,
    3. Ssempijja V,
    4. et al
    . Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis. 2009;199(7):945–949. doi:10.1086/597074. pmid:19220138
    OpenUrlCrossRefPubMed
  15. 15.
    1. Sobngwi-Tambekou J,
    2. Taljaard D,
    3. Lissouba P,
    4. et al
    . Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199(7):958–964. doi:10.1086/597208. pmid:19220143
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Mehta SD,
    2. Moses S,
    3. Agot K,
    4. et al
    . Medical male circumcision and herpes simplex virus 2 acquisition: posttrial surveillance in Kisumu, Kenya. J Infect Dis. 2013;208(11):1869–1876. doi:10.1093/infdis/jit371. pmid:23901089
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Nasio JM,
    2. Nagelkerke NJD,
    3. Mwatha A,
    4. Moses S,
    5. Ndinya-Achola JO,
    6. Plummer FA
    . Genital ulcer disease among STD clinic attenders in Nairobi: association with HIV-1 and circumcision status. Int J STD AIDS. 1996;7(6):410–414. doi:10.1258/0956462961918374. pmid:8940669
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Mehta SD,
    2. Moses S,
    3. Parker CB,
    4. Agot K,
    5. Maclean I,
    6. Bailey RC
    . Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS. 2012;26(9):1141–1149. doi:10.1097/QAD.0b013e328352d116. pmid:22382150
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Weiss HA,
    2. Thomas SL,
    3. Munabi SK,
    4. Hayes RJ
    . Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect. 2006;82(2):101–110. doi:10.1136/sti.2005.017442. pmid:16581731
    OpenUrlAbstract/FREE Full Text
  20. 20.
    1. Pintye J,
    2. Baeten JM,
    3. Manhart LE,
    4. et al
    ; Partners PrEP Study Team. Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples. Lancet Glob Health. 2014;2(11):e664–e671. doi:10.1016/S2214-109X(14)70315-8. pmid:25442691
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Otieno-Nyunya B,
    2. Bennett E,
    3. Bunnell R,
    4. et al
    ; Kenya AIDS Indicator Survey Study Team. Epidemiology of syphilis in Kenya: results from a nationally representative serological survey. Sex Transm Infect. 2011;87(6):521–525. doi:10.1136/sextrans-2011-050026. pmid:21917697
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Sobngwi-Tambekou J,
    2. Taljaard D,
    3. Nieuwoudt M,
    4. Lissouba P,
    5. Puren A,
    6. Auvert B
    . Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect. 2008;85(2):116–120. doi:10.1136/sti.2008.032334. pmid:19074928
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Mehta SD,
    2. Gaydos C,
    3. Maclean I,
    4. et al
    . The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex Transm Dis. 2012;39(4):276–280. doi:10.1097/OLQ.0b013e318240189c. pmid:22421693
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Tobian AAR,
    2. Kong X,
    3. Gravitt PE,
    4. et al
    . Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int J Cancer. 2011;129(12):2970–2975. doi:10.1002/ijc.25957. pmid:21462185
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Waskett JH,
    2. Morris BJ,
    3. Weiss HA
    . Errors in meta-analysis by Van Howe. Int J STD AIDS. 2009;20(3):216–220. doi:10.1258/ijsa.2009.008126. pmid:19255281
    OpenUrlCrossRefPubMed
  26. 26.
    1. Sobngwi-Tambekou J,
    2. Taljaard D,
    3. Nieuwoudt M,
    4. Lissouba P,
    5. Puren A,
    6. Auvert B
    . Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect. 2008;85(2):116–120. doi:10.1136/sti.2008.032334. pmid:19074928
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Mehta SD,
    2. Moses S,
    3. Agot K,
    4. et al
    . Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. J Infect Dis. 2009;200(3):370–378. doi:10.1086/600074. pmid:19545209
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Introcaso CE,
    2. Xu F,
    3. Kilmarx PH,
    4. Zaidi A,
    5. Markowitz LE
    . Prevalence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005-2010. Sex Transm Dis. 2013;40(7):521–525. doi:10.1097/01.OLQ.0000430797.56499.0d. pmid:23965763
    OpenUrlCrossRefPubMed
  29. 29.
    1. Tobian AAR,
    2. Serwadda D,
    3. Quinn TC,
    4. et al
    . Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360(13):1298–1309. doi:10.1056/NEJMoa0802556. pmid:19321868
    OpenUrlCrossRefPubMed
  30. 30.
    1. Sobngwi-Tambekou J,
    2. Taljaard D,
    3. Lissouba P,
    4. et al
    . Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199(7):958–964. doi:10.1086/597208. pmid:19220143
    OpenUrlCrossRefPubMed
  31. 31.
    1. Morris BJ,
    2. Bailis SA,
    3. Wiswell TE
    . Circumcision rates in the United States: rising or falling? What effect might the new affirmative pediatric policy statement have? Mayo Clin Proc. 2014;89(5):677–686. doi:10.1016/j.mayocp.2014.01.001. pmid:24702735
    OpenUrlCrossRefPubMed
  32. 32.
    1. Morris BJ,
    2. Klausner JD,
    3. Krieger JN,
    4. Willcox BJ,
    5. Crouse PD,
    6. Pollock N
    . Canadian Pediatrics Society position statement on newborn circumcision: a risk-benefit analysis revisited. Can J Urol. 2016;23(5):8495–8502. pmid:27705739
    OpenUrlPubMed
  33. 33.
    1. Morris BJ,
    2. Kennedy SE,
    3. Wodak AD,
    4. et al
    . Early infant male circumcision: systematic review, risk-benefit analysis, and progress in policy. World J Clin Pediatr. 2017;6(1):89–102. doi:10.5409/wjcp.v6.i1.89. pmid:28224100
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Morris BJ,
    2. Krieger JN
    . Non-therapeutic male circumcision. Paediatr Child Health. 2020;30(3):102–107. doi:10.1016/j.paed.2019.12.004
    OpenUrlCrossRef
  35. 35.↵
    1. Auvert B,
    2. Taljaard D,
    3. Lagarde E,
    4. Sobngwi-Tambekou J,
    5. Sitta R,
    6. Puren A
    . Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298. doi:10.1371/journal.pmed.0020298. pmid:16231970
    OpenUrlCrossRefPubMed
  36. 36.
    1. Bailey RC,
    2. Moses S,
    3. Parker CB,
    4. et al
    . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–656. doi:10.1016/S0140-6736(07)60312-2. pmid:17321310
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Gray RH,
    2. Kigozi G,
    3. Serwadda D,
    4. et al
    . Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–666. doi:10.1016/S0140-6736(07)60313-4. pmid:17321311
    OpenUrlCrossRefPubMed
  38. 38.↵
    World Health Organization (WHO); UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS Technical Consultation Male Circumcision and HIV Prevention: Research Implications for Policy and Programming, Montreux, 6-8 March 2007: Conclusions and Recommendations. WHO; 2007. Accessed June 29, 2022. https://apps.who.int/iris/bitstream/handle/10665/43751/9789241595988_eng.pdf
  39. 39.↵
    UNAIDS; World Health Organization (WHO). Voluntary Medical Male Circumcision: Remarkable Progress in the Scale Up of VMMC as an HIV Prevention Intervention in 15 ESA Countries. WHO; 2019. Accessed June 29, 2022. https://apps.who.int/iris/rest/bitstreams/1262110/retrieve
  40. 40.↵
    1. Blank S,
    2. Brady M,
    3. Buerk E,
    4. et al
    ; American Academy of Pediatrics Task Force on Circumcision. Circumcision policy statement. Pediatrics. 2012;130(3):585–586. doi:10.1542/peds.2012-1989. pmid:22926180
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Blank S,
    2. Brady M,
    3. Buerk E,
    4. et al
    ; American Academy of Pediatrics Task Force on Circumcision. Male circumcision. Pediatrics. 2012;130(3):e756–e785. doi:10.1542/peds.2012-1990. pmid:22926175
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Information for providers counseling male patients and parents regarding the prevention of HIV infection, STIs, and other health outcomes. Centers for Disease Control and Prevention. August 22, 2018. Accessed August 2, 2022. https://stacks.cdc.gov/view/cdc/58456
  43. 43.↵
    Centers for Disease Control and Prevention (CDC). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Background, Methods, and Synthesis of Scientific Information Used to Inform “Information for Providers to Share With Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and Other Health Outcomes.” CDC; 2018. Accessed June 29, 2022. https://stacks.cdc.gov/view/cdc/58457
  44. 44.↵
    1. Nayan M,
    2. Hamilton RJ,
    3. Juurlink DN,
    4. Austin PC,
    5. Jarvi KA
    . Circumcision and risk of HIV among males from Ontario, Canada. J Urol. 2022;207(2):424–430. doi:10.1097/JU.0000000000002234. pmid:34551593
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Giguère K,
    2. Vaziri M,
    3. Olivier C,
    4. et al
    . Characteristics of new HIV diagnoses over 1995–2019: a clinic-based study in Montréal, Canada. PLoS One. 2021;16(10):e0258383. doi:10.1371/journal.pone.0258383. pmid:34618875
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Millett GA,
    2. Flores SA,
    3. Marks G,
    4. Reed JB,
    5. Herbst JH
    . Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA. 2008;300(14):1674–1684. doi:10.1001/jama.300.14.1674. pmid:18840841
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Wiysonge CS,
    2. Kongnyuy EJ,
    3. Shey M,
    4. et al
    . Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2011;6(6):CD007496. doi:10.1002/14651858.CD007496.pub2. pmid:21678366
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Yuan T,
    2. Fitzpatrick T,
    3. Ko NY,
    4. et al
    . Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: a systematic review and meta-analysis of global data. Lancet Glob Health. 2019;7(4):e436–e447. doi:10.1016/S2214-109X(18)30567-9. pmid:30879508
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Templeton DJ,
    2. Jin F,
    3. Mao L,
    4. et al
    . Circumcision and risk of HIV infection in Australian homosexual men. AIDS. 2009;23(17):2347–2351. doi:10.1097/QAD.0b013e32833202b8. pmid:19752714
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Pando MA,
    2. Balan IC,
    3. Dolezal C,
    4. et al
    . Low frequency of male circumcision and unwillingness to be circumcised among MSM in Buenos Aires, Argentina: association with sexually transmitted infections. J Int AIDS Soc. 2013;16(1):18500. doi:10.7448/IAS.16.1.18500. pmid:23746302
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Morris BJ,
    2. Krieger JN
    . Circumcision and risk of HIV among males from Ontario, Canada. Letter. J Urol. 2022;207(2):479. doi:10.1097/JU.0000000000002337. pmid:34779237
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Nayan M,
    2. Hamilton RJ,
    3. Juurlink DN,
    4. Austin PC,
    5. Jarvi KA
    . Circumcision and risk of HIV among males from Ontario, Canada. Reply. J Urol. 2022;207(2):479–480. doi:10.1097/JU.0000000000002338. pmid:34779238
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Poynten IM,
    2. Jin F,
    3. Templeton DJ,
    4. et al
    . Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men. Sex Transm Dis. 2012;39(9):726–732. doi:10.1097/OLQ.0b013e31825d5cb8. pmid:22902671
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Balci M,
    2. Tuncel A,
    3. Baran I,
    4. et al
    . High-risk oncogenic human papilloma virus infection of the foreskin and microbiology of smegma in prepubertal boys. Urology. 2015;86(2):368–372. doi:10.1016/j.urology.2015.04.034. pmid:26199167
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Baeten JM,
    2. Donnell D,
    3. Kapiga SH,
    4. et al
    ; Partners in Prevention HSV/HIV Transmission Study Team. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS. 2010;24(5):737–744. doi:10.1097/QAD.0b013e32833616e0. pmid:20042848
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Grund JM,
    2. Bryant TS,
    3. Jackson I,
    4. et al
    . Association between male circumcision and women’s biomedical health outcomes: a systematic review. Lancet Glob Health. 2017;5(11):e1113–e1122. doi:10.1016/S2214-109X(17)30369-8. pmid:29025633
    OpenUrlCrossRefPubMed
  57. 57.↵
    1. Morris BJ,
    2. Hankins CA,
    3. Banerjee J,
    4. et al
    . Does male circumcision reduce women’s risk of sexually transmitted infections, cervical cancer, and associated conditions? Front Public Health. 2019;7:4. doi:10.3389/fpubh.2019.00004. pmid:30766863
    OpenUrlCrossRefPubMed
  58. 58.↵
    1. Warner L,
    2. Ghanem KG,
    3. Newman DR,
    4. Macaluso M,
    5. Sullivan PS,
    6. Erbelding EJ
    . Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis. 2009;199(1):59–65. doi:10.1086/595569. pmid:19086815
    OpenUrlCrossRefPubMed
  59. 59.
    1. Chemtob D,
    2. Op de Coul E,
    3. van Sighem A,
    4. Mor Z,
    5. Cazein F,
    6. Semaille C
    . Impact of male circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries. Isr J Health Policy Res. 2015;4(1):36. doi:10.1186/s13584-015-0033-8. pmid:26244087
    OpenUrlCrossRefPubMed
  60. 60.
    1. Baldwin SB,
    2. Wallace DR,
    3. Papenfuss MR,
    4. Abrahamsen M,
    5. Vaught LC,
    6. Giuliano AR
    . Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis. 2004;31(10):601–607. doi:10.1097/01.olq.0000140012.02703.10. pmid:15388997
    OpenUrlCrossRefPubMed
  61. 61.
    1. Daling JR,
    2. Madeleine MM,
    3. Johnson LG,
    4. et al
    . Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606–616. doi:10.1002/ijc.21009. pmid:15825185
    OpenUrlCrossRefPubMed
  62. 62.
    1. Nielson CM,
    2. Flores R,
    3. Harris RB,
    4. et al
    . Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1107–1114. doi:10.1158/1055-9965.EPI-06-0997. pmid:17548671
    OpenUrlAbstract/FREE Full Text
  63. 63.
    1. Hernandez BY,
    2. Wilkens LR,
    3. Zhu X,
    4. et al
    . Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis. 2008;197(6):787–794. doi:10.1086/528379. pmid:18284369
    OpenUrlCrossRefPubMed
  64. 64.
    1. Hernandez BY,
    2. Shvetsov YB,
    3. Goodman MT,
    4. et al
    . Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis. 2010;201(9):1340–1343. doi:10.1086/651607. pmid:20350160
    OpenUrlCrossRefPubMed
  65. 65.
    1. Nielson CM,
    2. Schiaffino MK,
    3. Dunne EF,
    4. Salemi JL,
    5. Giuliano AR
    . Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis. 2009;199(1):7–13. doi:10.1086/595567. pmid:19086813
    OpenUrlCrossRefPubMed
  66. 66.
    1. Lu B,
    2. Wu Y,
    3. Nielson CM,
    4. et al
    . Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis. 2009;199(3):362–371. doi:10.1086/596050. pmid:19133808
    OpenUrlCrossRefPubMed
  67. 67.
    1. Giuliano AR,
    2. Lazcano E,
    3. Villa LL,
    4. et al
    . Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer. 2009;124(6):1251–1257. doi:10.1002/ijc.24097. pmid:19089913
    OpenUrlCrossRefPubMed
  68. 68.
    1. Han JJ,
    2. Beltran TH,
    3. Song JW,
    4. Klaric J,
    5. Choi YS
    . Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncol. 2017;3(6):810–816. doi:10.1001/jamaoncol.2016.6192. pmid:28114440
    OpenUrlCrossRefPubMed
  69. 69.
    1. Aung ET,
    2. Fairley CK,
    3. Tabrizi SN,
    4. et al
    . Detection of human papillomavirus in urine among heterosexual men in relation to location of genital warts and circumcision status. Sex Transm Infect. 2018;94(3):222–225. doi:10.1136/sextrans-2016-053031. pmid:28866637
    OpenUrlAbstract/FREE Full Text
  70. 70.
    1. Aynaud O,
    2. Piron D,
    3. Bijaoui G,
    4. Casanova JM
    . Developmental factors of urethral human papillomavirus lesions: correlation with circumcision. BJU Int. 1999;84(1):57–60. doi:10.1046/j.1464-410x.1999.00104.x. pmid:10444125
    OpenUrlCrossRefPubMed
  71. 71.
    1. Van Wagoner NJ,
    2. Geisler WM,
    3. Sizemore JM Jr.,
    4. Whitley R,
    5. Hook EW III..
    Herpes simplex virus in African American heterosexual males: the roles of age and male circumcision. Sex Transm Dis. 2010;37(4):217–222. doi:10.1097/OLQ.0b013e3181c17b65. pmid:19910861
    OpenUrlCrossRefPubMed
  72. 72.
    1. Parker SW,
    2. Stewart AJ,
    3. Wren MN,
    4. Straton JAY,
    5. Gollow MM
    . Circumcision and sexually transmissible disease. Med J Aust. 1983;2(6):288–290. doi:10.5694/j.1326-5377.1983.tb122467.x. pmid:6689050
    OpenUrlCrossRefPubMed
  73. 73.
    1. Fergusson DM,
    2. Boden JM,
    3. Horwood LJ
    . Circumcision status and risk of sexually transmitted infection in young adult males: an analysis of a longitudinal birth cohort. Pediatrics. 2006;118(5):1971–1977. doi:10.1542/peds.2006-1175. pmid:17079568
    OpenUrlAbstract/FREE Full Text
  74. 74.
    1. Cook LS,
    2. Koutsky LA,
    3. Holmes KK
    . Circumcision and sexually transmitted diseases. Am J Public Health. 1994;84(2):197–201. doi:10.2105/AJPH.84.2.197. pmid:8296939
    OpenUrlCrossRefPubMed
  75. 75.
    1. Diseker RA III.,
    2. Peterman TA,
    3. Kamb ML,
    4. et al
    . Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect. 2000;76(6):474–479. doi:10.1136/sti.76.6.474. pmid:11221132
    OpenUrlAbstract/FREE Full Text
  76. 76.
    1. Templeton DJ,
    2. Jin F,
    3. Prestage GP,
    4. et al
    . Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia. J Infect Dis. 2009;200(12):1813–1819. doi:10.1086/648376. pmid:19911990
    OpenUrlCrossRefPubMed
  77. 77.
    1. Addanki KC,
    2. Pace DG,
    3. Bagasra O
    . A practice for all seasons: male circumcision and the prevention of HIV transmission. J Infect Dev Ctries. 2008;2(5):328–334. doi:10.3855/jidc.192
    OpenUrlCrossRefPubMed
  78. 78.
    1. Reynolds SJ,
    2. Shepherd ME,
    3. Risbud AR,
    4. et al
    . Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet. 2004;363(9414):1039–1040. doi:10.1016/S0140-6736(04)15840-6. pmid:15051285
    OpenUrlCrossRefPubMed
  79. 79.↵
    1. Kenyon CR
    . HIV prevalence correlated with circumcision prevalence and high-risk sexual behavior in India’s states: an ecological study. F1000Res. 2019;8:60. doi:10.12688/f1000research.17807.2. pmid:31316754
    OpenUrlCrossRefPubMed
  80. 80.↵
    1. Frisch M,
    2. Simonsen J
    . Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 2022;37(3):251–259. doi:10.1007/s10654-021-00809-6. pmid:34564796
    OpenUrlCrossRefPubMed
  81. 81.↵
    1. Hill AB
    . The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300. doi:10.1177/003591576505800503. pmid:14283879
    OpenUrlCrossRefPubMed
  82. 82.↵
    1. Szabo R,
    2. Short RV
    . How does male circumcision protect against HIV infection? BMJ. 2000;320(7249):1592–1594. doi:10.1136/bmj.320.7249.1592. pmid:10845974
    OpenUrlFREE Full Text
  83. 83.↵
    1. McCoombe SG,
    2. Short RV
    . Potential HIV-1 target cells in the human penis. AIDS. 2006;20(11):1491–1495. doi:10.1097/01.aids.0000237364.11123.98. pmid:16847403
    OpenUrlCrossRefPubMed
  84. 84.↵
    1. Hirbod T,
    2. Bailey RC,
    3. Agot K,
    4. et al
    . Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am J Pathol. 2010;176(6):2798–2805. doi:10.2353/ajpath.2010.090926. pmid:20395432
    OpenUrlCrossRefPubMed
  85. 85.
    1. Ganor Y,
    2. Zhou Z,
    3. Tudor D,
    4. et al
    . Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans–T cell conjugates. Mucosal Immunol. 2010;3(5):506–522. doi:10.1038/mi.2010.32. pmid:20571487
    OpenUrlCrossRefPubMed
  86. 86.
    1. Ganor Y,
    2. Bomsel M
    . HIV-1 transmission in the male genital tract. Am J Reprod Immunol. 2011;65(3):284–291. doi:10.1111/j.1600-0897.2010.00933.x. pmid:21114566
    OpenUrlCrossRefPubMed
  87. 87.↵
    1. Morris BJ,
    2. Wamai RG
    . Biological basis for the protective effect conferred by male circumcision against HIV infection. Int J STD AIDS. 2012;23(3):153–159. doi:10.1258/ijsa.2011.011228. pmid:22581866
    OpenUrlCrossRefPubMed
  88. 88.↵
    1. Gray RH,
    2. Serwadda D,
    3. Tobian AAR,
    4. et al
    . Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: analyses from the Rakai trials. PLoS Med. 2009;6(11):e1000187. doi:10.1371/journal.pmed.1000187. pmid:19936044
    OpenUrlCrossRefPubMed
  89. 89.
    1. Freeman EE,
    2. Weiss HA,
    3. Glynn JR,
    4. Cross PL,
    5. Whitworth JA,
    6. Hayes RJ
    . Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20(1):73–83. doi:10.1097/01.aids.0000198081.09337.a7. pmid:16327322
    OpenUrlCrossRefPubMed
  90. 90.
    1. Boily MC,
    2. Desai K,
    3. Masse B,
    4. Gumel A
    . Incremental role of male circumcision on a generalised HIV epidemic through its protective effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact. Sex Transm Infect. 2008;84 (Suppl 2):ii28–34. doi:10.1136/sti.2008.030346. pmid:18799489
    OpenUrlAbstract/FREE Full Text
  91. 91.
    1. Tobian AAR,
    2. Quinn TC
    . Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr Opin HIV AIDS. 2009;4(4):294–299. doi:10.1097/COH.0b013e32832c1881. pmid:19532067
    OpenUrlCrossRefPubMed
  92. 92.↵
    1. Bailey RC,
    2. Mehta SD
    . Circumcision’s place in the vicious cycle involving herpes simplex virus type 2 and HIV. J Infect Dis. 2009;199(7):923–925. doi:10.1086/597209. pmid:19367793
    OpenUrlCrossRefPubMed
  93. 93.↵
    1. Brito MO,
    2. Khosla S,
    3. Pananookooln S,
    4. et al
    . Sexual pleasure and function, coital trauma, and sex behaviors after voluntary medical male circumcision among men in the Dominican Republic. J Sex Med. 2017;14(4):526–534. doi:10.1016/j.jsxm.2017.01.020. pmid:28258953
    OpenUrlCrossRefPubMed
  94. 94.
    1. Mehta SD,
    2. Krieger JN,
    3. Agot K,
    4. et al
    . Circumcision and reduced risk of self-reported penile coital injuries: results from a randomized controlled trial in Kisumu, Kenya. J Urol. 2010;184(1):203–209. doi:10.1016/j.juro.2010.03.015. pmid:20483156
    OpenUrlCrossRefPubMed
  95. 95.↵
    1. Westercamp N,
    2. Mehta SD,
    3. Jaoko W,
    4. Okeyo TA,
    5. Bailey RC
    . Penile coital injuries in men decline after circumcision: results from a prospective study of recently circumcised and uncircumcised men in western Kenya. PLoS One. 2017;12(10):e0185917. doi:10.1371/journal.pone.0185917. pmid:29016638
    OpenUrlCrossRefPubMed
  96. 96.↵
    1. Kigozi G,
    2. Wawer M,
    3. Ssettuba A,
    4. et al
    . Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS. 2009;23(16):2209–2213. doi:10.1097/QAD.0b013e328330eda8. pmid:19770623
    OpenUrlCrossRefPubMed
  97. 97.↵
    1. de Witte L,
    2. Nabatov A,
    3. Pion M,
    4. et al
    . Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med. 2007;13(3):367–371. doi:10.1038/nm1541. pmid:17334373
    OpenUrlCrossRefPubMed
  98. 98.↵
    1. Schwartz O
    . Langerhans cells lap up HIV-1. Nat Med. 2007;13(3):245–246. doi:10.1038/nm0307-245. pmid:17342114
    OpenUrlCrossRefPubMed
  99. 99.↵
    1. Hirbod T,
    2. Kong X,
    3. Kigozi G,
    4. et al
    . HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog. 2014;10(10):e1004416. doi:10.1371/journal.ppat.1004416. pmid:25275513
    OpenUrlCrossRefPubMed
  100. 100.↵
    1. Fischetti L,
    2. Barry SM,
    3. Hope TJ,
    4. Shattock RJ
    . HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS. 2009;23(3):319–328. doi:10.1097/QAD.0b013e328321b778. pmid:19114867
    OpenUrlCrossRefPubMed
  101. 101.↵
    1. Dinh MH,
    2. Anderson MR,
    3. McRaven MD,
    4. et al
    . Visualization of HIV-1 interactions with penile and foreskin epithelia: clues for female-to-male HIV transmission. PLoS Pathog. 2015;11(3):e1004729. doi:10.1371/journal.ppat.1004729. pmid:25748093
    OpenUrlCrossRefPubMed
  102. 102.↵
    1. Morris BJ,
    2. Wiswell TE
    . Circumcision and lifetime risk of urinary tract infection: a systematic review and meta-analysis. J Urol. 2013;189(6):2118–2124. doi:10.1016/j.juro.2012.11.114. pmid:23201382
    OpenUrlCrossRefPubMed
  103. 103.↵
    1. Johansen TEB,
    2. Wagenlehner FME,
    3. Cho Y-H,
    4. Matsumoto T,
    5. Shoskes D,
    6. Krieger JN,
    7. Naber KG
    Morris BJ Krieger JN. Male circumcision protects against urinary tract infections. In: Johansen TEB, Wagenlehner FME, Cho Y-H, Matsumoto T, Shoskes D, Krieger JN, Naber KG, eds. Urogenital Infections and Inflammations. European Association of Urology; 2018:1–18.
  104. 104.↵
    1. Chukwuemeka Anyanwu L-J,
    2. Kashibu E,
    3. Edwin CP,
    4. Mohammad AM
    . Microbiology of smegma in boys in Kano, Nigeria. J Surg Res. 2012;173(1):21–25. doi:10.1016/j.jss.2011.04.057. pmid:21872267
    OpenUrlCrossRefPubMed
  105. 105.↵
    1. Price LB,
    2. Liu CM,
    3. Johnson KE,
    4. et al
    . The effects of circumcision on the penis microbiome. PLoS One. 2010;5(1):e8422. doi:10.1371/journal.pone.0008422. pmid:20066050
    OpenUrlCrossRefPubMed
  106. 106.
    1. Prodger JL,
    2. Gray R,
    3. Kigozi G,
    4. et al
    ; Rakai Genital Immunology Research Group. Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. AIDS. 2012;26(10):1319–1322. doi:10.1097/QAD.0b013e328354675c. pmid:22516874
    OpenUrlCrossRefPubMed
  107. 107.
    1. Prodger JL,
    2. Kaul R
    . The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field. AIDS Res Ther. 2017;14(1):49. doi:10.1186/s12981-017-0167-6. pmid:28893286
    OpenUrlCrossRefPubMed
  108. 108.
    1. Jayathunge PHM,
    2. McBride WJH,
    3. MacLaren D,
    4. Kaldor J,
    5. Vallely A,
    6. Turville S
    . Male circumcision and HIV transmission; what do we know? Open AIDS J. 2014;8(1):31–44. doi:10.2174/1874613601408010031. pmid:25317221
    OpenUrlCrossRefPubMed
  109. 109.↵
    1. Liu CM,
    2. Hungate BA,
    3. Tobian AAR,
    4. et al
    . Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio. 2013;4(2):e00076-13. doi:10.1128/mBio.00076-13. pmid:23592260
    OpenUrlAbstract/FREE Full Text
  110. 110.
    1. Aridogan IA,
    2. Izol V,
    3. Ilkit M
    . Superficial fungal infections of the male genitalia: a review. Crit Rev Microbiol. 2011;37(3):237–244. doi:10.3109/1040841X.2011.572862. pmid:21668404
    OpenUrlCrossRefPubMed
  111. 111.
    1. Onywera H,
    2. Williamson AL,
    3. Ponomarenko J,
    4. Meiring TL
    . The penile microbiota in uncircumcised and circumcised men: relationships with HIV and human papillomavirus infections and cervicovaginal microbiota. Front Med (Lausanne). 2020;7:383. doi:10.3389/fmed.2020.00383. pmid:32850898
    OpenUrlCrossRefPubMed
  112. 112.
    1. Onywera H,
    2. Williamson AL,
    3. Cozzuto L,
    4. et al
    . The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection. BMC Microbiol. 2020;20(1):78. doi:10.1186/s12866-020-01759-x. pmid:32252632
    OpenUrlCrossRefPubMed
  113. 113.
    1. Liu CM,
    2. Prodger JL,
    3. Tobian AAR,
    4. et al
    . Penile anaerobic dysbiosis as a risk factor for HIV infection. MBio. 2017;8(4):e00996-17. doi:10.1128/mBio.00996-17. pmid:28743816
    OpenUrlAbstract/FREE Full Text
  114. 114.
    1. Mehta SD,
    2. Green SJ,
    3. Maclean I,
    4. et al
    . Microbial diversity of genital ulcer disease in men enrolled in a randomized trial of male circumcision in Kisumu, Kenya. PLoS One. 2012;7(7):e38991. doi:10.1371/journal.pone.0038991. pmid:22848346
    OpenUrlCrossRefPubMed
  115. 115.
    1. Nelson DE,
    2. Dong Q,
    3. Van Der Pol B,
    4. et al
    . Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One. 2012;7(5):e36298. doi:10.1371/journal.pone.0036298. pmid:22606251
    OpenUrlCrossRefPubMed
  116. 116.↵
    1. Schneider J,
    2. Vadivelu S,
    3. Liao C,
    4. et al
    . Increased likelihood of bacterial pathogens in the coronal sulcus and urethra of uncircumcised men in a diverse group of HIV infected and uninfected patients in India. J Glob Infect Dis. 2012;4(1):6–9. doi:10.4103/0974-777X.93750. pmid:22529620
    OpenUrlCrossRefPubMed
  117. 117.↵
    1. O’Farrell N,
    2. Morison L,
    3. Moodley P,
    4. et al
    . Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa. J Acquir Immune Defic Syndr. 2006;43(1):69–77. doi:10.1097/01.qai.0000225014.61192.98. pmid:16878046
    OpenUrlCrossRefPubMed
  118. 118.↵
    1. Rahman Q,
    2. Xu Y,
    3. Lippa RA,
    4. Vasey PL
    . Prevalence of sexual orientation across 28 nations and its association with gender equality, economic development, and individualism. Arch Sex Behav. 2020;49(2):595–606. doi:10.1007/s10508-019-01590-0. pmid:31797225
    OpenUrlCrossRefPubMed
  119. 119.↵
    1. Traeger MW,
    2. Schroeder SE,
    3. Wright EJ,
    4. et al
    . Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676–686. doi:10.1093/cid/ciy182. pmid:29509889
    OpenUrlCrossRefPubMed
  120. 120.↵
    1. Frisch M,
    2. Lindholm M,
    3. Gronbaek M
    . Male circumcision and sexual function in men and women: a survey-based, cross-sectional study in Denmark. Int J Epidemiol. 2011;40(5):1367–1381. doi:10.1093/ije/dyr104. pmid:21672947
    OpenUrlCrossRefPubMed
  121. 121.↵
    All male circumcisions in Denmark must be registered. The Copenhagen Post. December 5, 2016. Accessed June 29, 2022. https://cphpost.dk/?p=75518
  122. 122.↵
    1. Hernán MA
    . The hazards of hazard ratios. Epidemiology. 2010;21(1):13–15. doi:10.1097/EDE.0b013e3181c1ea43. pmid:20010207
    OpenUrlCrossRefPubMed
  123. 123.↵
    1. Batson S,
    2. Greenall G,
    3. Hudson P
    . Review of the reporting of survival analyses within randomised controlled trials and the implications for meta-analysis. PLoS One. 2016;11(5):e0154870. doi:10.1371/journal.pone.0154870. pmid:27149107
    OpenUrlCrossRefPubMed
  124. 124.↵
    1. Hosmer DW,
    2. Lemeshow S,
    3. May S
    . Applied Survival Analysis: Regression Modeling of Time‐to‐Event Data. 2nd ed. Wiley; 2008.
  125. 125.↵
    1. Bruni L,
    2. Albero G,
    3. Serrano B,
    4. et al
    ; ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Disease Report. HPV Information Centre; 2015. Accessed June 29, 2022. https://hpvcentre.net/statistics/reports/DNK.pdf
  126. 126.↵
    1. Kjaer SK,
    2. Munk C,
    3. Falck Winther J,
    4. Jørgensen HO,
    5. Meijer CJLM,
    6. van den Brule AJC
    . Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1528–1533. doi:10.1158/1055-9965.EPI-04-0754. pmid:15941967
    OpenUrlAbstract/FREE Full Text
  127. 127.↵
    1. Hebnes JB,
    2. Munk C,
    3. Nøhr B,
    4. et al
    . Human papillomavirus infection among 2460 men in Denmark: prevalence in relation to age using 2 human papillomavirus DNA testing methods. Sex Transm Dis. 2015;42(8):463–467. doi:10.1097/OLQ.0000000000000315. pmid:26165439
    OpenUrlCrossRefPubMed
  128. 128.↵
    1. Svare EI,
    2. Kjaer SK,
    3. Worm AM,
    4. Osterlind A,
    5. Meijer CJLM,
    6. van den Brule AJC
    . Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002;78(3):215–218. doi:10.1136/sti.78.3.215. pmid:12238658
    OpenUrlAbstract/FREE Full Text
  129. 129.↵
    STD health equity. Centers for Disease Control and Prevention. Accessed June 29, 2022. https://www.cdc.gov/std/health-disparities/default.htm
  130. 130.↵
    1. Hooykaas C,
    2. van der Velde FW,
    3. van der Linden MM,
    4. van Doornum GJ,
    5. Coutinho RA
    . The importance of ethnicity as a risk factor for STDs and sexual behaviour among heterosexuals. Sex Transm Infect. 1991;67(5):378–383. doi:10.1136/sti.67.5.378. pmid:1743709
    OpenUrlAbstract/FREE Full Text
  131. 131.
    1. Wayal S,
    2. Hughes G,
    3. Sonnenberg P,
    4. et al
    . Ethnic variations in sexual behaviours and sexual health markers: findings from the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet Public Health. 2017;2(10):e458–e472. doi:10.1016/S2468-2667(17)30159-7. pmid:29057382
    OpenUrlCrossRefPubMed
  132. 132.↵
    1. Helsing B,
    2. Frisén A,
    3. Hwang CP
    . Sexual risk-taking among young Swedish men testing for STI. Eur J Contracept Reprod Health Care. 2021;26(2):155–159. doi:10.1080/13625187.2020.1821355. pmid:33006520
    OpenUrlCrossRefPubMed
  133. 133.↵
    University of Lausanne. Institute for Social and Preventive Medicine. Mapping of HIV/STI Behavioural Surveillance in Europe. ECDC Technical Report. European Centre for Disease Control and Prevention; 2009. Accessed June 29, 2022. https://www.ecdc.europa.eu/en/publications-data/mapping-hivsti-behavioural-surveillance-europe
  134. 134.↵
    1. Kettani H
    . Muslim population in Africa 1950–2020. Int J Environ Sci Dev. 2010;1(2):136–142. doi:10.7763/IJESD.2010.V1.27
    OpenUrlCrossRef
  135. 135.
    1. Kettani H
    . Muslim population in Asia 1950–2020. Int J Environ Sci Dev. 2010;1(2):143–153. doi:10.7763/IJESD.2010.V1.28
    OpenUrlCrossRef
  136. 136.↵
    1. Kettani H
    . Muslim population in Europe 1950 – 2020. Int J Environ Sci Dev. 2010;1(2):154–164. doi:10.7763/IJESD.2010.V1.29
    OpenUrlCrossRef
  137. 137.
    1. Kettani H
    . Muslim population in Oceania 1950 – 2020. Int J Environ Sci Dev. 2010;1(2):165–170. doi:10.7763/IJESD.2010.V1.30
    OpenUrlCrossRef
  138. 138.↵
    1. Kettani H
    . Muslim population in the Americas: 1950 – 2020. Int J Environ Sci Dev. 2010;1:127–135. Accessed August 2, 2022. http://www.ijesd.org/show-23-285-1.html
    OpenUrl
  139. 139.↵
    Immigration by sex, age, country of origin and citizenship. Statbank Denmark. Accessed July 26, 2022. https://www.statbank.dk/INDVAN
  140. 140.↵
    De danske jøder. Jødisk Informations Center. Accessed June 29, 2022. https://joediskinfo.dk/artikler/danske-joeder
  141. 141.↵
    1. Frisch M,
    2. Simonsen J
    . Ritual circumcision and risk of autism spectrum disorder in 0- to 9-year-old boys: national cohort study in Denmark. J R Soc Med. 2015;108(7):266–279. doi:10.1177/0141076814565942. pmid:25573114
    OpenUrlCrossRefPubMed
  142. 142.↵
    1. Frisch M,
    2. Simonsen J
    . Cultural background, non-therapeutic circumcision and the risk of meatal stenosis and other urethral stricture disease: two nationwide register-based cohort studies in Denmark 1977–2013. Surgeon. 2018;16(2):107–118. doi:10.1016/j.surge.2016.11.002. pmid:28017691
    OpenUrlCrossRefPubMed
  143. 143.↵
    1. Morris BJ,
    2. Waskett JH,
    3. Gray RH
    . Does sexual function survey in Denmark offer any support for male circumcision having an adverse effect? Int J Epidemiol. 2012;41(1):310–326. doi:10.1093/ije/dyr180. pmid:22422464
    OpenUrlCrossRefPubMed
  144. 144.
    1. Morris BJ,
    2. Wiswell TE
    . ‘Circumcision pain’ unlikely to cause autism. J R Soc Med. 2015;108(8):297. doi:10.1177/0141076815590404. pmid:26268916
    OpenUrlCrossRefPubMed
  145. 145.↵
    1. Morris BJ,
    2. Krieger JN
    . Re: Cultural background, non-therapeutic circumcision and the risk of meatal stenosis and other urethral stricture disease: two nationwide register-based cohort studies in Denmark 1977–2013. Surgeon. 2018;16(2):126–129. doi:10.1016/j.surge.2017.08.001. pmid:28869139
    OpenUrlCrossRefPubMed
  146. 146.↵
    1. Sneppen I,
    2. Thorup J
    . Foreskin morbidity in uncircumcised males. Pediatrics. 2016;137(5):e20154340. doi:10.1542/peds.2015-4340. pmid:27244821
    OpenUrlAbstract/FREE Full Text
  147. 147.
    Circumcision and autism. Arch Dis Child. 2015;100(4):369. doi:10.1136/archdischild-2015-308402. pmid:25715006
    OpenUrlFREE Full Text
  148. 148.
    1. Neyer A
    . The problem with articles on autism risks and how to evaluate studies. Or why circumcision is unlikely to increase rates of autism. The Chimerical Capuchin. January 10, 2015. Accessed June 29, 2022. https://chimericalcapuchin.wordpress.com/2015/01/10/the-problem-with-articles-on-autism-risks-and-how-to-evaluate-studies/
  149. 149.↵
    1. Sjøgren K
    . Researchers find link between autism and circumcision. Article in Danish. Videnskab.dk. January 9, 2015. Accessed June 29, 2022. https://videnskab.dk/krop-sundhed/forskere-finder-sammenhaeng-mellem-autisme-og-omskaering
  150. 150.↵
    1. Morris BJ,
    2. Moreton S,
    3. Krieger JN
    . Critical evaluation of arguments opposing male circumcision: a systematic review. J Evid Based Med. 2019;12(4):263–290. doi:10.1111/jebm.12361. pmid:31496128
    OpenUrlCrossRefPubMed
  151. 151.↵
    1. King JH,
    2. Hall MAK,
    3. Goodman RA,
    4. Posner SF
    . Life in data sets: locating and accessing data on the health of Americans across the life span. J Public Health Manag Pract. 2021;27(3):E126–E142. doi:10.1097/PHH.0000000000001079. pmid:31688741
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 10 (4)
Global Health: Science and Practice
Vol. 10, No. 4
August 30, 2022
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally
Brian J. Morris, Stephen Moreton, John N. Krieger, Jeffrey D. Klausner
Global Health: Science and Practice Aug 2022, 10 (4) e2100811; DOI: 10.9745/GHSP-D-21-00811

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally
Brian J. Morris, Stephen Moreton, John N. Krieger, Jeffrey D. Klausner
Global Health: Science and Practice Aug 2022, 10 (4) e2100811; DOI: 10.9745/GHSP-D-21-00811
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • MALE CIRCUMCISION FOR HIV AND STI PREVENTION IN MEN
    • ANALYZING CONTRARY EVIDENCE TO THE PROTECTION OF MC AGAINST STIS
    • CONCLUSIONS
    • Acknowledgments
    • Funding
    • Author contributions
    • Competing interests
    • Footnotes
    • Notes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Case for Using a Behavior Change Model to Design Interventions to Promote Respectful Maternal Care
  • Oxygen Inequity in the COVID-19 Pandemic and Beyond
  • Does the Current Global Health Agenda Lack Vision?
Show more COMMENTARY

Similar Articles

Subjects

  • Health Topics
    • Family Planning and Reproductive Health
    • HIV/AIDS
    • Infectious Diseases
US AIDJohns Hopkins Center for Communication ProgramsUniversity of Alberta

Follow Us On

  • Twitter
  • Facebook
  • LinkedIn
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers
  • GH Journals Database

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2023 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire